Navigation Links
Ukiah Home Oxygen Therapy Patients and Physicians Meet with Congressman Mike Thompson to Share Benefits of Quality Home Oxygen Care
Date:3/26/2008

further funding cuts to Medicare's home oxygen benefit, which could jeopardize our ability to provide critical patient care services, as well as hindering progress toward more thoughtful benefit reform in the future," said Peter Kelly, President of PPS and Chairman of the Council for Quality Respiratory Care (CQRC). "Additional cuts in the oxygen benefit are likely to create barriers to quality care for patients and their caregivers, as well as present new challenges for providers who are already struggling with unprecedented recent cutbacks in this benefit."

In addition to addressing concerns regarding changes to the Medicare home oxygen benefit, Pacific Pulmonary Service patients and staff expressed concerns regarding the recent Centers for Medicare and Medicaid Services (CMS) announcement about projected program reductions tied to Medicare's competitive bidding program. In a statement released by the non-profit Council for Quality Respiratory Care Kelly stated, "Changes stemming from new competitive bidding policies are more dramatic than anticipated, and the breadth of those changes should cause policymakers to carefully and thoughtfully assess the effects this restructuring is having on the health and well being of Medicare's respiratory patients before implementing additional changes."

The home oxygen community is currently braced for great uncertainty due to sweeping policy changes enacted by the Deficit Reduction Act of 2005 and the Medicare Modernization Act of 2003, both of which are taking effect during the coming year, and will cut benefits for home oxygen by more than $1.5 billion in 2009 and 2010. These changes will impact nearly 300,000 Americans, or 22 percent of the Medicare beneficiaries who rely on home oxygen for their home-based care.

"Changes to this benefit have the potential to influence quality and continuity of care for our patients, particularly in rural areas," said Bob Snee, Operations Manager. "Many of our pa
'/>"/>

SOURCE Pacific Pulmonary Services
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
2. More than 10,000 Medicare Patients in Montana Could Be Hit by Proposed Cuts to Home Oxygen Therapy; Access to Power Wheelchairs Would Also Decrease
3. Earths Oxygen May Have Arrived Earlier
4. San Diegos SeQual Technologies Loans 35 Portable Oxygen Units to Evacuees at Qualcomm Stadium
5. CQRC Statement on the NY Times Article on Medicares Home Oxygen Benefit
6. Statement from American Association for Homecare on New York Times Article about Home Oxygen Therapy
7. Link between chronic kidney disease and oxygen-deprived tissue
8. FOXO factor promotes survival of oxygen-deprived cancer cells
9. Infants with birthmarks received less oxygen in womb
10. OxySure(R) Systems, Inc. Named to 2008 Worlds Best Technologies (WBT) List For its Unique, Safe and Easy to Use Portable Emergency Oxygen Generator, Which Provides Medical Oxygen Without the Need for Compressed Tanks
11. Home Oxygen Care Leaders Say Presidents Budget Will Lead to Significant Patient Service Disruptions, Call for Thoughtful Reforms as Opposed to Repeated Cuts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...lleviates Insurance Claim Processing and Payment C...NTA, Dec. 2 SunTrust Ban...thcare receivables solution for medical and dental...Trust eClaim Revenue Gateway helps providers accel...nt collection and processing so that they can focu...
(Date:12/2/2008)...-- MicroPhage, Inc., http://www.microphage.com ,...ed,the company,s Board of Directors. Taussig was... Research Center in Denver, the nation,s leading i...m 1993 to 2006. His medical specialty,is pediatr...ge extensively and am impressed with its progress,...
(Date:12/2/2008)...to Connect - , , - Only 1 in 4 Teens Report...ngers - , , NEW YORK, Dec. 2 /PRNewswire/ ...ree America and MetLife Foundation shows that many...o communicate with their teens may be missing impo...ut drug and alcohol use. The national survey of mo...
(Date:12/2/2008)...RNewswire-USNewswire/ -- Fatigued medical resident...vision of work hour limits to improve patient safe...w Institute of Medicine report funded by HHS, Agen... The report is the result of a 15-month study by ...tween residents, work schedules, their performance...
Breaking Medicine News(10 mins):Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 2Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 3Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 4Health News:MicroPhage Selects Lynn Taussig, MD for Board of Directors 2Health News:Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones 2Health News:Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 4
...he 10-year international Human Genome Project (HGP...o carry the highest concentration of disease genes...ved to be associated with genetic disease. Over t...ellcome Trust's Sanger Centre, near Cambridge, eas...
...tances we see couples who are HIV sero discordant ...is HIV –1 positive and the wife is negative and th... because sexual intercourse carries a 1 in 500 ris...the female partner and through her to the fetus. ...
...ss what they dream about? Their own rat races! Rea...d by scientists at the Massachusetts Institute of ...ng about rat races and that they might in the long...understand how the human mind works. Most pet...
...ts, doctors in Ohio, the United States of America,...to rid him of a painful ulcer due to a weakened va...time a bovine vein is used in man to treat varicos... Toledo hospital's Jobst Vascular Center at Toledo...
Other Medicine News:Health News:Sperm washing helps couples 2
(Date:12/2/2008)...PRNewswire/ -- Horizon Therapeutics, Inc., a,priv...ced that two pivotal,Phase 3 trials evaluating it...,met all primary endpoints. HZT-501, a novel, pro...g ibuprofen and famotidine, demonstrated a,statis...non-steroidal,anti-inflammatory drug (NSAID)-indu...
(Date:12/1/2008)...AGO, Dec. 2 A study has... new technique for imaging the breast, is not affe...l status, two factors that limit the effectiveness...er. Results will be presented today at the annual ...ca (RSNA). , , "The ability of PEM to dete...
(Date:12/1/2008)...ewswire/ -- S*BIO Pte Ltd today announced the init...potent and orally-active JAK2 inhibitor, in leadin...hronic idiopathic myelofibrosis (CIMF). , , ... tolerability of SB1518 in patients with CIMF and ... 1 part of the study will assess the safety profil...
(Date:12/1/2008)...he Prox1 gene is a two-way switch that, if turned ...ogrammed so that they lose their identity and beco...MPHIS, Tenn., Dec. 1 S... have discovered that a certain differentiated cel...requires the constant expression of a gene called ...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 1Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 2BioSpecifics Technologies Corp Announces Sale of Stock in Private Placement Offering 2587 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 2Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 3Rwandas Gishwati Forest selected as site for historic conservation project 1899 1Rwandas Gishwati Forest selected as site for historic conservation project 1899 2Rwandas Gishwati Forest selected as site for historic conservation project 1899 3
...RE)--Apr 19, 2007 - Amgen,(NASDAQ: AMGN) today ann...d, double-blind, placebo-controlled, multicenter P...00 previously untreated,patients with extensive-st...um-containing chemotherapy. The study demonstrated...f death (overall,survival Aranesp compared to plac...
...Apr 18, 2007 - Critical,Therapeutics, Inc. (Nasdaq...rch demonstrating a role in chronic inflammatory,a...otein (HMGB1), a,pro-inflammatory mediator and nuc... May 2007 issue of Nature Immunology. The,publicat...es that,can stimulate immune cells to produce pote...
Other Medicine Technology:Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 2Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 3Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 4Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 5
Our high quality therapeutic drug monitoring reagents, calibrators and controls are available for most chemistry analyzers. Reproducible and accurate results for your laboratory needs.
The Emit 2000 Digoxin Calibrators are intended for use with the Emit 2000 Digoxin Assay.
The Newmarket Laboratories RPR kits use carbon particles coated with a mixture of lipid antigens, which will combine with antibody present in patients serum or plasma. The particles are suspended in
For use as a quality assurance reagent in assays detecting IgG and IgM antibodies to Toxoplasma gondii (TOXO IgG and TOXO IgM), IgG and IgM antibodies to rubella virus (rubella IgG and rubella IgM),
Medicine Products: